secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001193125-23-234766
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix terminates CEO, CFO, CLO for misconduct; appoints interim replacements
-------------------------------------------------------------------------------

- Keith Valentine, John Bostjancic, Patrick Keran fired for cause after investigation found repeated inappropriate and offensive conduct.
- Catherine Burzik (Board Chair) named Interim CEO; Geoffrey Gillespie (VP Corp Controller) Interim CFO; Puja Leekha (Chief Ethics & Compliance) Interim CLO.
- Company states misconduct unrelated to strategy, results, or previously filed financial statements.
- Board will immediately search for permanent successors; created Executive Committee with broad authority.
- Morgan Stanley conference participation on Sep 13 canceled; investor day planned for Sep 20 postponed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/d517366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-234766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer